Boundless Bio, Inc.
BOLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $55 | $43 | $37 | $19 |
| G&A Expenses | $18 | $12 | $9 | $6 |
| SG&A Expenses | $18 | $12 | $9 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | $0 | $0 | $0 |
| Operating Expenses | $72 | $55 | $46 | $25 |
| Operating Income | -$73 | -$55 | -$46 | -$25 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $8 | $5 | $1 | $0 |
| Pre-Tax Income | -$65 | -$49 | -$46 | -$25 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$65 | -$49 | -$46 | -$25 |
| % Margin | – | – | – | – |
| EPS | -3.85 | -2.22 | -2.06 | -1.13 |
| % Growth | -73.4% | -7.8% | -82.3% | – |
| EPS Diluted | -3.85 | -2.22 | -2.06 | -1.13 |
| Weighted Avg Shares Out | 17 | 22 | 22 | 22 |
| Weighted Avg Shares Out Dil | 17 | 22 | 22 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $5 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$64 | -$54 | -$46 | -$25 |
| % Margin | – | – | – | – |